UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 16,
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Achieve Life Sciences Charts.
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences, Inc. News

Form EFFECT - Notice of Effectiveness
Tuesday 7 May 2024 (19 hours ago) • Edgar (US Regulatory)
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Tuesday 7 May 2024 (1 day ago) • GlobeNewswire Inc.
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Thursday 25 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Thursday 11 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

More Achieve Life Sciences, Inc. News Articles